PISCATAWAY, NJ, April 18, 2005 -- Sabinsa Corporation, a manufacturer and supplier of high quality herbal extracts, cosmeceuticals, minerals and specialty fine chemicals, today announced that a recent study conducted by Vanderbilt University Medical Center found the company's Selenium SeLECT brand L-(+)-Selenomethionine compound more than twice as bioavailable as selenium in the form of selenite.
"This study further confirms that not all forms of selenium are equal, and that selenomethionine, specifically our Selenium SeLECT, is more available to be absorbed and used by the body," stated Todd Norton, president, Sabinsa Corporation. Dr. Vladimir Badmaev, Sabinsa's vice president of scientific and medical affairs adds, "the University is in the process of preparing for three additional studies using Selenium SeLECT and we look forward to hearing about the results of those studies."
The study entitled "Effectiveness of selenium supplements in a low-selenium area of China" involved 120 subjects with an average selenium intake of 10 micrograms per day, well below the recommended dietary allowance of 55 micrograms per day. Participants were given selenium supplements in either the form of sodium selenite or selenomethionine (Selenium SeLECT was used) to determine the amount of selenium in both forms needed to optimize levels in the blood. Less than half the amount of selenium as selenomethionine was needed to reach optimal levels compared to selenium as selenite. When in the form of selenomethionine, which is an organic compound and the predominant form of selenium found in natural occurring food products, selenium is more than twice as available to be absorbed and used by the body. This study was accepted for publication in the American Journal of Clinical Nutrition, and an additional paper on the results is planned.
Selenium SeLECT is Sabinsa Corporation's branded L-(+)-Selenomethionine compound, the most bioavailable, pure and safe form of selenium. Selenium is a trace mineral that is found naturally in soil and has been shown to have several positive health benefits. When consumed, selenium enters the body to form selenoproteins and glutathione, the body's antioxidant immune system detoxifier. Currently, the National Cancer Institute (NCI) is using Selenium SeLECT for its Selenium and Vitamin E Cancer Prevention Trial (SELECT), a 12-year study focused on the role of selenium and vitamin E, both separately and together, in the prevention of prostate cancer.
Shortly after this study began the following qualified health claim was issued by the FDA, "selenium may reduce the risk of certain cancers. Some scientific evidence suggests that consumption of selenium may reduce the risk of certain forms of cancer. However, FDA has determined that this evidence is limited and not conclusive." Additionally, NCI is conducting the Prevention of Alzheimer's by Selenium SeLECT and Vitamin E (PREADVISE) trial in conjunction with SELECT. This study is researching the role of selenium and vitamin E in preventing memory damage with age, including Alzheimer's and other diseases that can affect the brain. Selenium SeLECT was chosen for these NCI studies because of its high quality. The worldwide quality standard or USP monograph for selenomethionine is based on Selenium SeLECT. For more information visit www.seleniumselect.com.
Sabinsa Corporation, founded in 1988, is a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals. Sabinsa's mission is to provide alternative and complementary natural products for human nutrition and well-being. Over the past nine years, Sabinsa has brought to market more than thirty standardized botanical extracts and privately funded several clinical studies in conjunction with prestigious institutions in support of these products. With more than thirty scientists working full time conducting ongoing research both in India and the United States, Sabinsa continues to develop and patent phytonutrients for the world market. All products intended for human consumption are certified Kosher. For more information visit www.sabinsa.com .
For more information contact Courtney Jacobs at 801-538-0777 ext. 102 or [email protected].
# # #